EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury

Rui-Ming Deng, Juan Zhou

International Immunopharmacology · 2023-10 · 123 · 110714

DOI: 10.1016/j.intimp.2023.110714 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-10. Verfasst von Rui-Ming Deng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China; The Affiliated Ganzhou Hospit…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocardial Ischemia. Die Arbeit wurde bisher 184-mal zitiert (Crossref) und nennt 256 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia has a high incidence and mortality rate, and reperfusion is currently the standard intervention. However, reperfusion may lead to further myocardial damage, known as myocardial ischemia/reperfusion injury (MIRI). There are currently no effective clinical treatments for MIRI. The PI3K/Akt signaling pathway is involved in cardiovascular health and disease and plays an important role in reducing myocardial infarct size and restoring cardiac function after MIRI. Activation of the PI3K/Akt pathway provides myocardial protection through synergistic upregulation of antioxidant, anti-inflammatory, and autophagy activities and inhibition of mitochondrial dysfunction and cardiomyocyte apoptosis. Many studies have shown that PI3K/Akt has a significant protective effect against MIRI. Here, we reviewed the molecular regulation of PI3K/Akt in MIRI and summarized the molecular mechanism by which PI3K/Akt affects MIRI, the effects of ischemic preconditioning and ischemic postconditioning, and the role of related drugs or activators targeting PI3K/Akt in MIRI, providing novel insights for the formulation of myocardial protection strategies. This review provides evidence of the role of PI3K/Akt activation in MIRI and supports its use as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryMyocardial IschemiaHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionApoptosis

Stichwörter der Autor:innen

ApoptosisMyocardial ischemia–reperfusion injury (MIRI)Oxidative stressPI3K/Akt pathwayTherapeutic target

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Anesthesiology, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China; The Affiliated Ganzhou Hospital of Nanchang University, 16 Meiguan Avenue, Ganzhou, Jiangxi Provinc…
  • Department of thyroid and Breast Surgery, Ganzhou People's Hospital, 16 Meiguan Avenue, Ganzhou, Jiangxi Province 341000, PR China; The Affiliated Ganzhou Hospital of Nanchang University, 16 Meiguan Avenue, Ganzhou, Jia…

Zitieren

APA

Deng, R. M., & Zhou, J. (2023). The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury. International Immunopharmacology, 123, 110714. https://doi.org/10.1016/j.intimp.2023.110714

Vancouver

Deng RM, Zhou J. The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury. International Immunopharmacology. 2023;123:110714. doi:10.1016/j.intimp.2023.110714

BibTeX
@article{Deng2023,
  author = {Deng, Rui-Ming and Zhou, Juan},
  title = {The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {123},
  pages = {110714},
  doi = {10.1016/j.intimp.2023.110714}
}
Kostenlos starten →